Your browser doesn't support javascript.
loading
DEB-TACE with irinotecan versus C-TACE for unresectable intrahepatic cholangiocarcinoma: a prospective clinical study.
Wang, Junxiao; Xue, Yaoqin; Liu, Rui; Wen, Zhenyu; Ma, Zhenhu; Yang, Xiang; Yu, Lingxiang; Yang, Bin; Xie, Hui.
Afiliação
  • Wang J; Aerospace Medical Center, Aerospace Center Hospital, Beijing, China.
  • Xue Y; Senior Department of Oncology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Liu R; Senior Department of Oncology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Wen Z; Department of Interventional Therapy, Shanxi Province Cancer Hospital, Taiyuan, China.
  • Ma Z; Department of Interventional Vascular, Aerospace Center Hospital, Beijing, China.
  • Yang X; Senior Department of Oncology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Yu L; Senior Department of Oncology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Yang B; Senior Department of Oncology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Xie H; Senior Department of Liver Disease, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Front Bioeng Biotechnol ; 10: 1112500, 2022.
Article em En | MEDLINE | ID: mdl-36714623

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça